Literature DB >> 9076519

Natural human anti-Gal alpha(1,3)Gal antibodies react with human mucin peptides.

M S Sandrin1, H A Vaughan, P X Xing, I F McKenzie.   

Abstract

We have recently demonstrated that both antibodies to Gal alpha(1,3)Gal, and the Gal alpha(1,3)Gal binding lectin (IB4), bind a synthetic peptide (DAHWESWL), there being a similar recognition of carbohydrate and peptide structures. We now report that the anti-Gal alpha(1,3)Gal antibodies and IB4 lectin also react with peptides encoded by mucin genes (MUC 1, 3, 4)-sequences known to be rich in serine, threonine and proline. This activity was demonstrated (1) by the ability of mucin derived peptides to block the reaction of anti-Gal alpha(1,3)Gal antibodies and IB4 lectin with a Gal alpha(1,3)Gal+ pig endothelial cell line; the reactions were specific and did not occur with a random peptide containing the same sequences or with other mucin peptides; (2) by the fact that anti-mucin1 antibodies could react with the Gal alpha(1,3)Gal expressed after transfection of COS cells (Gal alpha(1,3)Gal-,Muc1-) with cDNA encoding the pig alpha, 3galactosyltransferase; and (3) that the IB4 lectin and anti-Gal alpha(1,3)Gal antibodies could react with mucin 1 found on the surface of human breast cancer cells. Thus natural occurring anti-Gal alpha(1,3)Gal antibodies found in all human serum can react with self (Muc1) peptides expressed in large amounts on the surface of tumour cells but not on normal cells. The findings are of interest and serve to explain the previously reported findings that human cells can, at times, express Gal alpha(1,3)Gal; such expression is an artefact, the reaction is due to the phenomenon described herein, i.e. that anti-Gal alpha(1,3)Gal antibodies react with mucin peptides.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9076519     DOI: 10.1023/a:1018521217276

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  33 in total

1.  Identification of a peptide which binds to the carbohydrate-specific monoclonal antibody B3.

Authors:  R Hoess; U Brinkmann; T Handel; I Pastan
Journal:  Gene       Date:  1993-06-15       Impact factor: 3.688

2.  Monoclonal antibodies reactive with mucin expressed in breast cancer.

Authors:  P X Xing; J J Tjandra; S A Stacker; J G Teh; C H Thompson; P J McLaughlin; I F McKenzie
Journal:  Immunol Cell Biol       Date:  1989-06       Impact factor: 5.126

3.  Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells.

Authors:  D L Barnd; M S Lan; R S Metzgar; O J Finn
Journal:  Proc Natl Acad Sci U S A       Date:  1989-09       Impact factor: 11.205

4.  Immunological and structural features of the protein core of human polymorphic epithelial mucin.

Authors:  M R Price; F Hudecz; C O'Sullivan; R W Baldwin; P M Edwards; S J Tendler
Journal:  Mol Immunol       Date:  1990-08       Impact factor: 4.407

5.  Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes.

Authors:  M S Sandrin; H A Vaughan; P L Dabkowski; I F McKenzie
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-01       Impact factor: 11.205

6.  Differentiation antigens expressed by epithelial cells in the lactating breast are also detectable in breast cancers.

Authors:  J Arklie; J Taylor-Papadimitrious; W Bodmer; M Egan; R Millis
Journal:  Int J Cancer       Date:  1981-07-15       Impact factor: 7.396

7.  Peptide mimicry of the meningococcal group C capsular polysaccharide.

Authors:  M A Westerink; P C Giardina; M A Apicella; T Kieber-Emmons
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

8.  Immunological mimicry between N-acetyl-beta-D-glucosamine and cytokeratin peptides. Evidence for a microbially driven anti-keratin antibody response.

Authors:  A R Shikhman; M W Cunningham
Journal:  J Immunol       Date:  1994-05-01       Impact factor: 5.422

Review 9.  Gal alpha (1,3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies.

Authors:  M S Sandrin; I F McKenzie
Journal:  Immunol Rev       Date:  1994-10       Impact factor: 12.988

10.  Distribution of the major xenoantigen (gal (alpha 1-3)gal) for pig to human xenografts.

Authors:  I F McKenzie; P X Xing; H A Vaughan; J Prenzoska; P L Dabkowski; M S Sandrin
Journal:  Transpl Immunol       Date:  1994-06       Impact factor: 1.708

View more
  20 in total

1.  Activity of MUC1 cancer antigen-binding plasma anti-α-galactoside antibody correlates inversely with size of autologous lipoprotein(a).

Authors:  Jessy John; Vasantha Kalaivani; Mandagini Geetha; Padinjaradath S Appukuttan
Journal:  Exp Biol Med (Maywood)       Date:  2019-08

2.  The xenograft antigen bound to Griffonia simplicifolia lectin 1-B(4). X-ray crystal structure of the complex and molecular dynamics characterization of the binding site.

Authors:  Wolfram Tempel; Sarah Tschampel; Robert J Woods
Journal:  J Biol Chem       Date:  2001-11-19       Impact factor: 5.157

3.  Plasma anti-α-galactoside antibody mediates lipoprotein(a) binding to macrophages.

Authors:  Binu Sheela; Genu George; Geetha Mandagini; Padinjaradath S Appukuttan
Journal:  Glycoconj J       Date:  2016-08-19       Impact factor: 2.916

4.  Low reactivity of tumor MUC1-binding natural anti-α-galactoside antibody is a risk factor for breast cancer.

Authors:  Jessy John; Kurian Cherian; Thomas Abraham; Padinjaradath S Appukuttan
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-19

5.  Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein.

Authors:  V Karanikas; L A Hwang; J Pearson; C S Ong; V Apostolopoulos; H Vaughan; P X Xing; G Jamieson; G Pietersz; B Tait; R Broadbent; G Thynne; I F McKenzie
Journal:  J Clin Invest       Date:  1997-12-01       Impact factor: 14.808

6.  Induction of cytolytic anti-Gal antibodies in alpha-1,3-galactosyltransferase gene knockout mice by oral inoculation with Escherichia coli O86:B7 bacteria.

Authors:  Karla J Posekany; H Keith Pittman; John F Bradfield; Carl E Haisch; Kathryn M Verbanac
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

7.  Complement activation by human IgG antibodies to galactose-α-1,3-galactose.

Authors:  Jens Magnus Bernth Jensen; Nick Stub Laursen; Rasmus Kjeldsen Jensen; Gregers Rom Andersen; Jens Christian Jensenius; Uffe B Skov Sørensen; Steffen Thiel
Journal:  Immunology       Date:  2020-07-14       Impact factor: 7.397

8.  The xenograft antigen in complex with GS-1-B4 lectin: crystallization and preliminary X-ray analysis.

Authors:  W Tempel; L A Lipscomb; J P Rose; R J Woods
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2001-10-25

Review 9.  Bridging innate and adaptive antitumor immunity targeting glycans.

Authors:  Anastas Pashov; Bejatolah Monzavi-Karbassi; Gajendra P S Raghava; Thomas Kieber-Emmons
Journal:  J Biomed Biotechnol       Date:  2010-06-15

10.  Plasma anti-α-galactoside antibody binds to serine- and threonine-rich peptide sequence of apo(a) subunit in Lp(a).

Authors:  M Geetha; V Kalaivani; P S Sabarinath; P S Appukuttan
Journal:  Glycoconj J       Date:  2014-04-11       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.